|
Investigating the Increased Risk of Falls in Individuals With Parkinson's Disease Treated With Deep Brain Stimulation
RECRUITINGN/ASponsored by University of Alabama at Birmingham
Actively Recruiting
PhaseN/A
SponsorUniversity of Alabama at Birmingham
Started2026-08-01
Est. completion2027-11-01
Eligibility
Age30 Years – 80 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07725315
Summary
The purpose of this pilot study is to assess changes in thinking and movement after deep brain stimulator implantation. The study will also examine whether these changes are related to the risk of falls.
Eligibility
Age: 30 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria: * Age between 30-80, patient has elected to undergo DBS surgery as part of routine care, cleared for deep brain stimulation surgery as part of routine care by the movement disorders committee. Refractory motor symptoms such as dyskinesias, wearing off, and/or motor fluctuations, causing significant disability, despite reasonable attempts at medical management, as determined by the consensus DBS committee, able to walk, Patient is available for follow-up over the length of the study Exclusion Criteria: Patient's insurance will not cover the costs of surgery with investigational devices, Medical contraindications such as current uncontrolled hypertension, heart disease, coagulopathy, or other conditions contraindicating DBS surgery or stimulation, self-report of lack of clear levodopa response, requires a walker or wheelchair for mobility \-
Conditions3
Deep Brain StimulationPARKINSON DISEASE (Disorder)Parkinson's Disease
Locations1 site
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of Alabama at Birmingham
Started2026-08-01
Est. completion2027-11-01
Eligibility
Age30 Years – 80 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07725315